Scientists coax nerve fibers to re-grow after spinal cord injury

Researchers at the University of Michigan Medical School and Johns Hopkins University have developed a treatment that helps animals with traumatic spinal cord injuries grow new nerve fibers.

The study has implications for treating people who may face amputation of an arm after an injury in which nerves are wrenched from the spinal cord. Called brachial plexus avulsion, this type of injury occurs when an arm is pulled violently away from the body. In people, it most often occurs in motorcycle accidents or during childbirth.

The findings will be published in the July 18 issue of the Proceedings of the National Academy of Sciences.

The researchers chose to mimic this type of injury in their study, because it involves nerves at the boundary between the spinal cord and the peripheral nervous system that connects to the rest of the body.

Rats with nerve injuries that received a nerve-transplant and were treated with an enzyme called sialidase, grew more than twice as many new nerve fibers in the spinal cord compared to untreated rats. Moreover, the researchers found that the new fibers were made by nerve cells residing in the spinal cord.

"A new treatment to enhance our current surgical management of brachial plexus avulsion in people would be welcomed by patients and surgeons alike," says Lynda Yang, M.D., assistant professor of neurosurgery at the University of Michigan Medical School and lead author of the study.

While surgeons can sometimes reattach the yanked nerves to the spinal cord, this treatment is not as effective as physicians or patients would like. This is in part because nerves in the brain and spinal cord, unlike those in the rest of the body, fail to grow new nerve fibers.

"If you sever your finger, it can be surgically reattached, and nerve fibers typically grow back so that you can use your finger again; in contrast, the injured brain and spinal cord are rocky terrain for nerve fiber growth. Finding ways to smooth that road might help the nerve fibers to re-grow,” says co-author Ronald Schnaar, Ph.D., professor of pharmacology and neuroscience at the Institute of Basic Biomedical Sciences at Johns Hopkins University.

Nerves in the brain and spinal cord are surrounded by signals from other cells in the injured area that stop them from growing. Molecules in the spinal cord, called axon regeneration inhibitors, ARIs, are known to stop nerve fibers from growing. The researchers tested three enzymes, including sialidase, which are known to destroy ARIs.

Rats that received a nerve transplant followed by treatment with sialidase showed the greatest improvement in nerve re-growth.

In the next phase of research, Yang will determine whether the new nerves are able to re-establish muscle control. "We're very interested in seeing how much function you can get back," she says.

The researchers were funded by the Department of Neurosurgery at the University of Michigan Medical School, and two branches of the National Institutes of Health – the National Institute of Neurological Disorders and Stroke and the National Heart, Lung, and Blood Institute.

Additional contributing authors are Ileana Lorenzini, Katarina Vajn, Andrea Mountney, and Lawrence Schramm from Johns Hopkins University.

Source: Johns Hopkins University

Related stories:

A fine balance
Once a toddler has mastered the art of walking, it seems to come naturally for the rest of her life. But walking and running require a high degree of coordination between the left and right sides of the body. Now researchers at the Salk Institute for Biological Studies have shown how a class of spinal cord neurons, known as V3 neurons, makes sure that one side of the body doesn't get ahead of the other.
Protein shown to play a key role in normal development of nervous system
A protein that enables nerve cells to communicate with each other plays a key role in controlling the developing nervous system. Research into how that protein helps precise connections to form among nerve cells may provide a basis for eventual treatments for patients who suffer injuries to their nervous system, including spinal cord injury.
New study proves that pain is not a symptom of arthritis, pain causes arthritis
Pain is more than a symptom of osteoarthritis, it is an inherent and damaging part of the disease itself, according to a study published today in journal Arthritis and Rheumatism. More specifically, the study revealed that pain signals originating in arthritic joints, and the biochemical processing of those signals as they reach the spinal cord, worsen and expand arthritis. In addition, researchers found that nerve pathways carrying pain signals transfer inflammation from arthritic joints to the spine and back again, causing disease at both ends.
Researchers identify novel mechanism to reduce nervous system inflammation
Researchers at Georgetown University Medical Center have discovered a new way to limit inflammation caused by the activation of microglia - key immune cells in the brain. Although the role of such cells is to "clean up damage" after injury, they often worsen the damage by releasing toxic inflammatory factors.
Rare genetic disorder gives clues to autism, epilepsy, mental retardation
A rare genetic disorder called tuberous sclerosis complex (TSC) is yielding insight into a possible cause of some neurodevelopmental disorders: structural abnormalities in neurons, or brain cells. Researchers in the F.M. Kirby Neurobiology Center at Children's Hospital Boston, led by Mustafa Sahin, MD, PhD, and Xi He, PhD, also found that normal neuronal structure can potentially be restored.
Researchers disclose key advance in treating spinal cord injuries
Researchers in Rochester, N.Y., and Colorado have shown that manipulating stem cells prior to transplantation may hold the key to overcoming a critical obstacle to using stem cell technology to repair spinal cord injuries.
Sole use of impaired limb improves recovery in spinal cord injury
A new study finds that following minor spinal cord injury, rats that had to use impaired limbs showed full recovery due to increased growth of healthy nerve fibers and the formation of new nerve cell connections. Published in the September 17 issue of The Journal of Neuroscience, these findings help explain how physical therapy advances recovery, and support the use of rehabilitation therapies that specifically target impaired limbs in people with brain and spinal cord injuries.
Gene therapy for chronic pain gets first test in people
This week, University of Michigan scientists will begin a phase 1 clinical trial for the treatment of cancer-related pain, using a novel gene transfer vector injected into the skin to deliver a pain-relieving gene to the nervous system.

News discussion:

Medicine & Health news